EZ1 fundamentals
An in-depth look to Enzon Pharmaceuticals Inc. operating, investing, and financing activities
EZ1 free cash flow for Q2 24 is 225 k EUR. For 2023, EZ1 free cash flow was 1.18 M EUR and operating cash flow was 1.18 M EUR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM